A novel pyridoindole improves the recovery of residual hearing following cochlear implantation after a single preoperative applicationMichael Nieratschker(Medical University of Vienna), Hans Rommelspacher(CellAct Pharma (Germany))bioRxiv (Cold Spring Harbor Laboratory)February 19, 202410.1101/2024.02.14.580226Cited by 1SaveCiteExport RISWatch citationsRelated PapersA preoperative dose of the pyridoindole AC102 improves the recovery of residual hearing in a gerbil animal model of cochlear implantation|Cell Death and Disease|2024|9A novel pyridoindole improves the recovery of residual hearing following cochlear implantation after a single preoperative application|Research Square|2024|0